Characterization and selection of antibodies for precision diagnostics using Biacore surface plasmon resonance technology

Speaker

Abstract

Immunoassay developers are constantly striving to create tests that address unmet diagnostic needs. A critical prerequisite for good assay performance is the design, production, and characterization of reagents that are highly sensitive and selective. This includes selecting the analyte of interest to measure, the sample matrices in which measurements will be made, as well as determining the critical success factors for the assay, for example, sensitivity, throughput, and dynamic range.

Biacore™ surface plasmon resonance (SPR) has become an important optical biosensing technology due to its real-time, label-free, and automated analysis. Additionally, the robustness and precision of modern SPR instruments has seen the technology widely applied for the rapid and ultra-sensitive detection of biological analytes, with applications in medical diagnostics, environmental monitoring, and agriculture.

This presentation will provide an overview of Biacore SPR as a diagnostic tool, highlighting how it can aid and simplify immunoassay reagent selection and accelerate the development of fit for purpose diagnostic assays.

Learning objectives

  • How surface plasmon resonance technology aid the selection and optimization of reagents for diagnostic tests
  • How SPR has been applied as diagnostic tool in clinic

Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
C.E. CREDITS
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...
Loading Comments...
Show Resources